About Oncoceutics
Oncoceutics is a company based in Philadelphia (United States) founded in 2009 was acquired by Chimerix in January 2021.. The company has 18 employees as of December 31, 2020. Oncoceutics operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others.
- Headquarter Philadelphia, United States
- Employees 18 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Oncoceutics
- Total Funding Total Funding
- Total Rounds 5
- Last Round Grant — $1.7M
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2017 | Amount | Grant - Oncoceutics | Valuation |
investors |
|
| Aug, 2016 | Amount | Grant - Oncoceutics | Valuation |
investors |
|
| Oct, 2015 | Amount | Series A - Oncoceutics | Valuation | Spring Mountain Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Oncoceutics
Oncoceutics has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Chimerix and Spring Mountain Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Antiviral oral therapeutics are developed for infectious diseases and cancers.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Oncoceutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Oncoceutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Oncoceutics Comparisons
Competitors of Oncoceutics
Oncoceutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Oncoceutics
Frequently Asked Questions about Oncoceutics
When was Oncoceutics founded?
Oncoceutics was founded in 2009 and raised its 1st funding round 5 years after it was founded.
Where is Oncoceutics located?
Oncoceutics is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
How many employees does Oncoceutics have?
As of Dec 31, 2020, the latest employee count at Oncoceutics is 18.
What does Oncoceutics do?
Oncoceutics is a clinical-stage drug development company focused on oncology. Oncoceutics is developing ONC201, an oral, small-molecule drug that acts against numerous tumor types by sparing healthy cells and targeting the most potent tumor suppressor pathways. The company is currently in clinical trials at cancer centers including Massachusetts General Hospital, Rutgers Cancer Institute of New Jersey, Fox Chase Cancer Center, and at the University of Texas MD Anderson Cancer Center. ONC201 is in multiple trials at various stages and several analogs with differentiated profiles in preclinical testing. ONC201 is an Imipridone- Imipridones are a novel class of small molecule anti-cancer compounds that possess a unique three-ring heterocyclic core structure with two substitutable basic amines. ONC201, which directly antagonizes a GPCR called DRD2.
Who are the top competitors of Oncoceutics?
Oncoceutics's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
Who are Oncoceutics's investors?
Oncoceutics has 3 investors. Key investors include HHS, Chimerix, and Spring Mountain Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.